CSF3 and acute myeloid leukemia: This scenario is similar to that of molecules commonly employed in clinical practice for the mobilization of either hematopoietic progenitors or acute myeloid leukemia (AML) blasts into PB, such as granulocyte-colony-stimulating factor or plerixafor [44–46].